Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections

Neglected parasitic diseases remain a major public health issue worldwide, especially in tropical and subtropical areas. Human parasite diversity is very large, ranging from protozoa to worms. In most cases, more effective and new drugs are urgently needed. Previous studies indicated that the gold(I) drug auranofin (Ridaura®) is effective against several parasites. Among new gold(I) complexes, the phosphole-containing gold(I) complex {1-phenyl-2,5-di(2-pyridyl)phosphole}AuCl (abbreviated as GoPI) is an irreversible inhibitor of both purified human glutathione and thioredoxin reductases. GoPI-sugar is a novel 1-thio-β-d-glucopyranose 2,3,4,6-tetraacetato-S-derivative that is a chimera of the structures of GoPI and auranofin, designed to improve stability and bioavailability of GoPI. These metal-ligand complexes are of particular interest because of their combined abilities to irreversibly target the essential dithiol/selenol catalytic pair of selenium-dependent thioredoxin reductase activity, and to kill cells from breast and brain tumors. In this work, screening of various parasites—protozoans, trematodes, and nematodes—was undertaken to determine the in vitro killing activity of GoPI-sugar compared to auranofin. GoPI-sugar was found to efficiently kill intramacrophagic Leishmania donovani amastigotes and adult filarial and trematode worms.

• Publication year

  2020

• Venue

  Molecules

• Publication date

  2020-11-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.3390/molecules25215075PMID 33139647PMCID 7663263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Auranofin

  2020cited by this paper
• Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases

  2019cited by this paper
• Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni

  2019cited by this paper
• pH-Responsive Dual Drug-Loaded Nanocarriers Based on Poly (2-Ethyl-2-Oxazoline) Modified Black Phosphorus Nanosheets for Cancer Chemo/Photothermal Therapy

  2019cited by this paper
• Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis

  2018cited by this paper
• Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents

  2017cited by this paper
• The Enzymatic and Structural Basis for Inhibition of Echinococcus granulosus Thioredoxin Glutathione Reductase by Gold(I)

  2017cited by this paper
• Biochemical analysis of leishmanial and human GDP-Mannose Pyrophosphorylases and selection of inhibitors as new leads

  2017cited by this paper
• In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B

  2017cited by this paper
• In vivo and in vitro auranofin activity against Trypanosoma cruzi: Possible new uses for an old drug.

  2016cited by this paper
• Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent

  2016cited by this paper
• Auranofin-induced oxidative stress causes redistribution of the glutathione pool in Taenia crassiceps cysticerci.

  2015cited by this paper
• Dibenzylideneacetones Are Potent Trypanocidal Compounds That Affect the Trypanosoma cruzi Redox System

  2015cited by this paper
• “Squalenoylcurcumin” Nanoassemblies as Water‐Dispersible Drug Candidates with Antileishmanial Activity

  2015cited by this paper
• Repurposing Auranofin as a Lead Candidate for Treatment of Lymphatic Filariasis and Onchocerciasis

  2015cited by this paper
• Conversion of zirconacyclopentadienes into metalloles: Fagan-Nugent reaction and beyond.

  2015cited by this paper
• TGF-β2 induces Grb2 to recruit PI3-K to TGF-RII that activates JNK/AP-1-signaling and augments invasiveness of Theileria-transformed macrophages

  2015cited by this paper
• Auranofin: Repurposing an Old Drug for a Golden New Age

  2015cited by this paper
• Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo

  2014cited by this paper
• Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.

  2014cited by this paper
• Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia.

  2014cited by this paper
• Antiglioma activity of GoPI-sugar, a novel gold(I)-phosphole inhibitor: chemical synthesis, mechanistic studies, and effectiveness in vivo.

  2014cited by this paper
• The level of H2O2 type oxidative stress regulates virulence of Theileria-transformed leukocytes

  2013cited by this paper
• Thioredoxin Glutathione Reductase-Dependent Redox Networks in Platyhelminth Parasites

  2013cited by this paper
• A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia

  2013cited by this paper
• Schistosomiasis

  2013cited by this paper
• Redox‐Active Agents in Reactions Involving the Trypanothione/Trypanothione Reductase‐based System to Fight Kinetoplastidal Parasites

  2013cited by this paper
• The biological activity of auranofin: implications for novel treatment of diseases

  2012cited by this paper
• A high throughput drug screen for Entamoeba histolytica identifies a new lead and target

  2012cited by this paper
• WormAssay: A Novel Computer Application for Whole-Plate Motion-based Screening of Macroscopic Parasites

  2012cited by this paper
• Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni.

  2011cited by this paper
• Thioredoxin glutathione reductase: its role in redox biology and potential as a target for drugs against neglected diseases.

  2011cited by this paper
• A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition

  2011cited by this paper
• Chiral and extended π-conjugated bis(2-pyridyl)phospholes as assembling N,P,N pincers for coordination-driven synthesis of supramolecular [2,2]paracyclophane analogues.

  2011cited by this paper
• Mapping the Catalytic Cycle of Schistosoma mansoni Thioredoxin Glutathione Reductase by X-ray Crystallography*

  2010cited by this paper
• In vitro killing action of auranofin on Taenia crassiceps metacestode (cysticerci) and inactivation of thioredoxin–glutathione reductase (TGR)

  2010cited by this paper
• Parasites and poverty: the case of schistosomiasis.

  2010cited by this paper
• Single-dose liposomal amphotericin B for visceral leishmaniasis in India.

  2010cited by this paper
• Über bakteriologische Forschung

  2010cited by this paper
• TGF-b2 Induction Regulates Invasiveness of Theileria-Transformed Leukocytes and Disease Susceptibility

  2010cited by this paper
• Linked Thioredoxin-Glutathione Systems in Platyhelminth Parasites

  2010cited by this paper
• Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin

  2009cited by this paper
• A Sugar‐Modified Phosphole Gold Complex with Antiproliferative Properties Acting as a Thioredoxin Reductase Inhibitor in MCF‐7 Cells

  2008cited by this paper
• New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications

  2008cited by this paper
• Platyhelminth Mitochondrial and Cytosolic Redox Homeostasis Is Controlled by a Single Thioredoxin Glutathione Reductase and Dependent on Selenium and Glutathione*

  2008cited by this paper
• Review on the experience with live attenuated vaccines against tropical theileriosis in Tunisia: considerations for the present and implications for the future.

  2008cited by this paper
• The JNK/AP‐1 pathway upregulates expression of the recycling endosome rab11a gene in B cells transformed by Theileria

  2007cited by this paper
• Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

  2007cited by this paper
• The effects by neuroleptics, antimycotics and antibiotics on disulfide reducing enzymes from the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.

  2007cited by this paper
• Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.

  2007cited by this paper
• Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents.

  2006cited by this paper
• Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.

  2006cited by this paper
• Alteration of host cell phenotype by Theileria annulata and Theileria parva: mining for manipulators in the parasite genomes.

  2006cited by this paper
• Taking the Myc is bad for Theileria.

  2005cited by this paper
• Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.

  2005cited by this paper
• Mechanistic Studies on a Novel, Highly Potent Gold-Phosphole Inhibitor of Human Glutathione Reductase*

  2005cited by this paper
• Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.

  2005cited by this paper
• c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes

  2005cited by this paper
• Gold complexes in the treatment of rheumatoid arthritis.

  2004cited by this paper
• Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions.

  2004cited by this paper
• Dual Action of Antimonial Drugs on Thiol Redox Metabolism in the Human Pathogen Leishmania donovani*

  2004cited by this paper
• Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon

  2003cited by this paper
• Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.

  2003cited by this paper
• Thiol compounds from a free‐living pathogenic opportunistic amoeba, Acanthamoeba polyphaga

  2002cited by this paper
• Development of Pd–Cu catalyzed cross-coupling of terminal acetylenes with sp2-carbon halides

  2002cited by this paper
• The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase.

  2002cited by this paper
• Hijacking of Host Cell IKK Signalosomes by the Transforming Parasite Theileria

  2002cited by this paper
• Bromination studies of the 2,3-dimethylnaphthazarin core allowing easy access to naphthazarin derivatives.

  2001cited by this paper
• Phosphole-containing pi-conjugated systems: from model molecules to polymer films on electrodes.

  2001cited by this paper
• Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress

  2000cited by this paper
• First Crystal Structure of a Medicinally Relevant Gold Protein Complex: Unexpected Binding of

  2000cited by this paper
• Loss of matrix metalloproteinase 9 activity in Theileria annulata-attenuated cells is at the transcriptional level and is associated with differentially expressed AP-1 species.

  2000cited by this paper
• Transformation of leukocytes by Theileria parva and T. annulata.

  1999cited by this paper
• Mechanism(s) of attenuation of Theileria annulata vaccine cell lines

  1999cited by this paper
• Human Placenta Thioredoxin Reductase

  1998cited by this paper
• Upregulation of Jun and Fos family members and permanent JNK activity lead to constitutive AP-1 activation in Theileria-transformed leukocytes.

  1998cited by this paper
• Auranofin.

  1997cited by this paper
• Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

  1997cited by this paper
• Macrophage‐parasite relationship in theileriosis. Reversible phenotypic and functional dedifferentiation of macrophages infected with Theileria annulata

  1997cited by this paper
• The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro.

  1997cited by this paper
• Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

  1996cited by this paper
• Kinetics and Mechanism of the Reaction between Serum Albumin and Auranofin (and Its Isopropyl Analogue) in Vitro.

  1996cited by this paper
• Theileria transformation of bovine leukocytes: a parasite model for the study of lymphoproliferation.

  1996cited by this paper
• Infection with Theileria annulata induces expression of matrix metalloproteinase 9 and transcription factor AP-1 in bovine leucocytes.

  1995cited by this paper
• Metal compounds in therapy and diagnosis.

  1993cited by this paper
• Metabolism and functions of trypanothione in the Kinetoplastida.

  1992cited by this paper
• Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.

  1989influential reference
• Trypanothione is the primary target for arsenical drugs against African trypanosomes.

  1989cited by this paper
• Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes.

  1986cited by this paper
• Molecular mechanisms of action of auranofin and other gold complexes as related to their biologic activities.

  1983cited by this paper
• Gold in medicine

  1982cited by this paper
• RHEUMATOID ARTHRITIS AND ITS TREATMENT BY GOLD SALTS

  1934cited by this paper
• Transforming Growth Factor (cid:2) 2 Promotes Transcription of COX2 and EP4 , Leading to a Prostaglandin E 2 -Driven Autostimulatory Loop That Enhances Virulence of Theileria annulata -Transformed Macrophages

  year unknowncited by this paper

• Golden keys to inflammation: decoding the anti-inflammatory mechanisms of gold(I) and gold(III) complexes (2010–present)

  2026cites this paper
• Auranofin and iodoquinol as promising repurposing drugs against filamentous fungi: antifungal activity and cellular alterations

  2026cites this paper
• Amebicidal Effect of Adamantane–Azole Gold(I) Complexes: Cell Death Mechanisms and Synergistic Action with Chlorhexidine against Acanthamoeba castellanii

  2026cites this paper
• Gold(III) Complexes with Aromatic Cyano-Substituted Bisdithiolate Ligands as Potential Anticancer and Antimicrobial Agents

  2025cites this paper
• The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs

  2025cites this paper
• Functional utility of gold complexes with phosphorus donor ligands in biological systems.

  2025cites this paper
• Crystal structure and polymorphic forms of auranofin revisited

  2025cites this paper
• Investigation of In Vitro and In Vivo Anti-leishmanial Activity of Auranofin on Leishmania Infantum

  2025cites this paper
• Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin

  2025cites this paper
• Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.

  2024cites this paper
• The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug

  2024cites this paper
• Auranofin is lethal against feline Tritrichomonas foetus in vitro but ineffective in cats with naturally occurring infection.

  2024cites this paper
• Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections

  2024influential citation
• Auranofin is active against Histoplasma capsulatum and reduces the expression of virulence-related genes

  2024cites this paper
• Metal (Au, Pt, Pd, Ni) Bis(dithiolene) complexes as dual-action agents combating cancer and trypanosomatid infections.

  2024cites this paper
• Molecular mechanisms and clinical implications of the gold drug auranofin

  2023cites this paper
• Pentasubstituted Phospholes with Extended π-Conjugated Arm – Synthesis, Electrochemistry, Spectra and Quantum Chemical Calculations

  2023cites this paper
• Structure of Leishmania donovani 6-Phosphogluconate Dehydrogenase and Inhibition by Phosphine Gold(I) Complexes: A Potential Approach to Leishmaniasis Treatment

  2023influential citation
• A Hybrid of Amodiaquine and Primaquine Linked by Gold(I) Is a Multistage Antimalarial Agent Targeting Heme Detoxification and Thiol Redox Homeostasis

  2022cites this paper
• Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus

  2022cites this paper
• Thioredoxin reductase selenoproteins from different organisms as potential drug targets for treatment of human diseases.

  2022cites this paper
• Biological Activity of Gold Compounds against Viruses and Parasitosis: A Systematic Review

  2022influential citation
• Transcriptional changes of proteins of the thioredoxin and glutathione systems in Acanthamoeba spp. under oxidative stress – an RNA approach

  2022cites this paper
• Synthesis of Diorganylphosphine Oxides Bearing Hetarylalkyl Moieties and Study of Their Antimicrobial Activities

  2022cites this paper
• Speciation Analysis Highlights the Interactions of Auranofin with the Cytoskeleton Proteins of Lung Cancer Cells

  2022cites this paper
• Identification of Promising Antifungal Drugs against Scedosporium and Lomentospora Species after Screening of Pathogen Box Library

  2021cites this paper
• Autonomous Non Antioxidant Roles for Fasciola hepatica Secreted Thioredoxin-1 and Peroxiredoxin-1

  2021cites this paper
• Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans

  2021cites this paper
• Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs

  2021cites this paper
• Antimicrobial effect of auranofin against Acanthamoeba spp.

  2021cites this paper